These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26602398)

  • 1. [Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].
    Nakauchi K; Kawazoe H; Miyajima R; Waizumi C; Rokkaku Y; Tsuneoka K; Higuchi N; Fujiwara M; Kojima Y; Yakushijin Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(11):1397-400. PubMed ID: 26602398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].
    Miyajima R; Kawazoe H; Tsuneoka K; Fujiwara M; Kojima Y; Yakushijin Y
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):537-40. PubMed ID: 23848028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.
    Kawazoe H; Sumikawa S; Nakauchi K; Yakushijin Y; Yamamoto Y; Watanabe Y; Tanaka A; Araki H
    Int J Clin Pharm; 2017 Dec; 39(6):1291-1297. PubMed ID: 29027645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiology and management of venous pain during intravenous administration of oxaliplatin].
    Matsuyama K; Mishima H; Ueno H; Kajihara K; Morioka A; Morimoto S; Yamauchi K; Honda Y; Komori K; Tsujinaka T
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):411-4. PubMed ID: 21403443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of vascular pain due to drop-infusion of oxaliplatin (L-OHP) in peripheral vein with heated infusion route].
    Yatate M; Kimura M; Iwasaki Y; Kamura M; Yokoi M; Uchitani S; Mizumoto T; Matsushita H
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):589-91. PubMed ID: 22504683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigating the incidence of injection-site reactions associated with administration of oxaliplatin into a peripheral vein and management local adverse reactions].
    Hibi S; Tatematsu M; Nishio S; Miyatani M; Tosaki K; Ohara M; Maeda T; Tomita N; Kawai M; Ina K; Oishi K; Muro K
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1447-52. PubMed ID: 21918339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO).
    Hata T; Honda M; Kobayashi M; Toyokawa A; Tsuda M; Tokunaga Y; Takase K; Miyake M; Morita S; Nagata N; Sakamoto J; Gosho M; Mishima H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1209-15. PubMed ID: 26560483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
    Sugimoto M; Matsui M; Harada M; Yamauchi Y; Moriyama N; Andou K; Yamamoto M; Yamaoka H; Ono C; Ishikawa M; Kamo N; Ikeda T; Yamaoka K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):969-74. PubMed ID: 19542717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction of angialgia during peripheral administration of oxaliplatin mixed with dexamethasone].
    Shiotsuka Y; Uebuchi M; Hamada S; Morita N; Moriyama A; Yamashita M; Ichikawa Y; Fujii H; Matsuo A; Kuhara H; Ikuta Y; Ikeshima S; Kuramoto M; Fujii K; Shimada S
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1583-6. PubMed ID: 23064078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feasibility of peripheral vein during FOLFOX/FOLFIRI chemotherapy through peripheral venous system].
    Kimura T; Iwase K; Aono T; Nakai S; Fujii M; Nishikawa K; Matsuda C; Shimada K; Hirota M; Nasu S; Wada D; Hasegawa J; Tanaka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1889-94. PubMed ID: 19011337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer.
    Ohta H; Hayashi T; Murai S; Shiouchi H; Ando Y; Kumazawa S; Ito K; Ikeda Y; Matsuoka H; Maeda K; Kawada K; Yasuda K; Yamada S
    Cancer Chemother Pharmacol; 2017 May; 79(5):1021-1029. PubMed ID: 28391355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
    Nagata K; Egashira N; Yamada T; Watanabe H; Yamauchi Y; Oishi R
    Support Care Cancer; 2012 May; 20(5):951-5. PubMed ID: 21519948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
    To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
    J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter Feasibility Study with S-1, Oxaliplatin and Oral Leucovorin (SOL) for the Patients with Untreated Metastatic Colorectal Cancer: The Result of Final Analysis.
    Lu M; Wang Y; Liu W; Bai C; Xu J; Shen L
    Hepatogastroenterology; 2014 Jun; 61(132):1018-23. PubMed ID: 26158159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylactic reaction to oxaliplatin--a case of colon cancer].
    Sagawa T; Sato Y; Abe S; Okuda T; Araki N; Takahari D; Okamoto T; Takayama T; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2093-6. PubMed ID: 17197761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical administration of oxaliplatin for patients previously treated for refractory advanced or recurrent colorectal cancer].
    Takahari D; Tsuji Y; Sagawa T; Honda K; Sumiyoshi T; Yoshizaki N; Kuroiwa G; Kondo H
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):49-54. PubMed ID: 16410698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Injection Site Reactions for Peripheral Intravenous Oxaliplatin Infusion and Potential Remedies.
    Handa S; Kuroiwa R; Miyano M; Shimizu H; Kamei D; Takei H; Sonou H; Yamamoto H; Murayama J; Sato A; Kato Y
    Gan To Kagaku Ryoho; 2016 Aug; 43(8):985-8. PubMed ID: 27539041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
    Falcone A; Masi G; Allegrini G; Danesi R; Pfanner E; Brunetti IM; Di Paolo A; Cupini S; Del Tacca M; Conte P
    J Clin Oncol; 2002 Oct; 20(19):4006-14. PubMed ID: 12351598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.